Annual CFF
-$167.40 M
-$47.17 M-39.23%
31 December 2023
Summary:
GoodRx Holdings annual cash flow from financing activities is currently -$167.40 million, with the most recent change of -$47.17 million (-39.23%) on 31 December 2023. During the last 3 years, it has fallen by -$1.07 billion (-118.48%). GDRX annual CFF is now -118.48% below its all-time high of $905.82 million, reached on 31 December 2020.GDRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$172.13 M
-$171.26 M-19822.34%
30 September 2024
Summary:
GoodRx Holdings quarterly cash flow from financing activities is currently -$172.13 million, with the most recent change of -$171.26 million (-19822.34%) on 30 September 2024. Over the past year, it has dropped by -$158.42 million (-1155.87%). GDRX quarterly CFF is now -117.35% below its all-time high of $992.12 million, reached on 30 September 2020.GDRX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$459.57 M
-$158.42 M-52.61%
30 September 2024
Summary:
GoodRx Holdings TTM cash flow from financing activities is currently -$459.57 million, with the most recent change of -$158.42 million (-52.61%) on 30 September 2024. Over the past year, it has dropped by -$412.99 million (-886.71%). GDRX TTM CFF is now -145.18% below its all-time high of $1.02 billion, reached on 30 September 2020.GDRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDRX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.2% | -1155.9% | -886.7% |
| 3 y3 years | -118.5% | -4017.9% | -252.3% |
| 5 y5 years | -576.8% | - | - |
GDRX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -118.5% | at low | <-9999.0% | at low | -1405.4% | at low |
| 5 y | 5 years | -118.5% | at low | -117.3% | at low | -145.2% | at low |
| alltime | all time | -118.5% | at low | -117.3% | at low | -145.2% | at low |
GoodRx Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$172.13 M(>+9900.0%) | -$459.57 M(+52.6%) |
| June 2024 | - | -$864.00 K(-99.5%) | -$301.15 M(-4.2%) |
| Mar 2024 | - | -$160.97 M(+28.2%) | -$314.28 M(+87.7%) |
| Dec 2023 | -$167.40 M(+39.2%) | -$125.61 M(+816.4%) | -$167.40 M(+259.4%) |
| Sept 2023 | - | -$13.71 M(-2.1%) | -$46.58 M(-14.7%) |
| June 2023 | - | -$13.99 M(-0.7%) | -$54.58 M(+27.2%) |
| Mar 2023 | - | -$14.09 M(+194.4%) | -$42.91 M(-64.3%) |
| Dec 2022 | -$120.23 M | -$4.79 M(-78.0%) | -$120.23 M(-5.3%) |
| Sept 2022 | - | -$21.71 M(+832.6%) | -$126.91 M(+16.0%) |
| June 2022 | - | -$2.33 M(-97.5%) | -$109.37 M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$91.40 M(+697.2%) | -$107.91 M(+253.5%) |
| Dec 2021 | -$30.53 M(-103.4%) | -$11.46 M(+174.3%) | -$30.53 M(-76.6%) |
| Sept 2021 | - | -$4.18 M(+383.2%) | -$130.44 M(-115.1%) |
| June 2021 | - | -$865.00 K(-93.8%) | $865.87 M(+0.2%) |
| Mar 2021 | - | -$14.02 M(-87.4%) | $864.20 M(-4.6%) |
| Dec 2020 | $905.82 M(-1753.5%) | -$111.37 M(-111.2%) | $905.82 M(-10.9%) |
| Sept 2020 | - | $992.12 M(<-9900.0%) | $1.02 B(+3957.6%) |
| June 2020 | - | -$2.53 M(-109.2%) | $25.07 M(-9.2%) |
| Mar 2020 | - | $27.60 M | $27.60 M |
| Dec 2019 | -$54.78 M(+121.5%) | - | - |
| Dec 2018 | -$24.73 M | - | - |
FAQ
- What is GoodRx Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for GoodRx Holdings?
- What is GoodRx Holdings annual CFF year-on-year change?
- What is GoodRx Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for GoodRx Holdings?
- What is GoodRx Holdings quarterly CFF year-on-year change?
- What is GoodRx Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for GoodRx Holdings?
- What is GoodRx Holdings TTM CFF year-on-year change?
What is GoodRx Holdings annual cash flow from financing activities?
The current annual CFF of GDRX is -$167.40 M
What is the all time high annual CFF for GoodRx Holdings?
GoodRx Holdings all-time high annual cash flow from financing activities is $905.82 M
What is GoodRx Holdings annual CFF year-on-year change?
Over the past year, GDRX annual cash flow from financing activities has changed by -$47.17 M (-39.23%)
What is GoodRx Holdings quarterly cash flow from financing activities?
The current quarterly CFF of GDRX is -$172.13 M
What is the all time high quarterly CFF for GoodRx Holdings?
GoodRx Holdings all-time high quarterly cash flow from financing activities is $992.12 M
What is GoodRx Holdings quarterly CFF year-on-year change?
Over the past year, GDRX quarterly cash flow from financing activities has changed by -$158.42 M (-1155.87%)
What is GoodRx Holdings TTM cash flow from financing activities?
The current TTM CFF of GDRX is -$459.57 M
What is the all time high TTM CFF for GoodRx Holdings?
GoodRx Holdings all-time high TTM cash flow from financing activities is $1.02 B
What is GoodRx Holdings TTM CFF year-on-year change?
Over the past year, GDRX TTM cash flow from financing activities has changed by -$412.99 M (-886.71%)